Eric Easom - Chief Executive Officer, Director at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ANTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Eric Easom - trading volume in the past year for AN2 Therapeutics, Inc.

Holdings reported by Eric Easom for AN2 Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.07M $1.07M $1.00 Nov 18, 2024 Indirect
Common Stock 101K $101K $1.00 Nov 18, 2024 Direct
Stock Option (right to buy) 198K Mar 15, 2024 Direct Common Stock

Transactions reported by Eric Easom for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.